Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation.
Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis, a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20. Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono- to di-methylated H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment.
Frye
Michaela
M
Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Cambridge, United Kingdom.
Fisher
Amanda G
AG
Watt
Fiona M
FM
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D000078404:Epidermal Cells; D018859:Hair Follicle / Q000166:cytology / Q000502:physiology; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism; D006657:Histones / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*
D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D016271:Proto-Oncogene Proteins c-myc; C012589:trichostatin A; D006655:Histone Deacetylases; D008239:Lysine
Nat Rev Cancer. 2006 Nov;6(11):846-56
17060944
Curr Opin Genet Dev. 2006 Oct;16(5):518-24
16919447
J Cell Biol. 2006 Jan 2;172(1):139-49
16391002
Drug Discov Today. 2006 Feb;11(3-4):91-3
16533705
Ernst Schering Res Found Workshop. 2006;(57):1-27
16568946
J Biol Chem. 2006 May 5;281(18):12760-6
16517599
Curr Biol. 2006 May 23;16(10):971-81
16713953
J Invest Dermatol. 2006 Jul;126(7):1459-68
16778814
EMBO J. 2006 Jun 21;25(12):2723-34
16724113
Mol Cell Biol. 2000 Jan;20(2):556-62
10611234
Curr Biol. 2001 Apr 17;11(8):558-68
11369200
Nat Genet. 2001 Jun;28(2):165-8
11381265
Science. 2001 Aug 10;293(5532):1074-80
11498575
Genes Dev. 2001 Aug 15;15(16):2069-82
11511539
Curr Biol. 2002 Jul 9;12(13):1086-99
12121615
Nature. 2002 Oct 24;419(6909):857-62
12397363
Genes Dev. 2003 May 1;17(9):1115-29
12695333
Development. 2003 Jun;130(12):2793-808
12736221
EMBO Rep. 2003 Jun;4(6):575-80
12776177
Nat Rev Cancer. 2003 Jun;3(6):444-51
12778134
Development. 2003 Nov;130(21):5241-55
12954714
Development. 2003 Dec;130(24):6049-63
14573520
Nat Rev Cancer. 2004 Jul;4(7):562-8
15229481
Genes Dev. 2004 Oct 1;18(19):2315-35
15466484
J Dent Res. 1981 Aug;60 Spec No C:1611-20
6943171
Nucleic Acids Res. 1990 Feb 25;18(4):1068
2156225
J Biol Chem. 1990 Oct 5;265(28):17174-9
2211619
Blood. 1993 May 1;81(9):2272-82
7683214
EMBO J. 1995 Aug 15;14(16):3946-57
7664735
Genes Dev. 1997 Nov 1;11(21):2869-82
9353256
Development. 1999 Jun;126(11):2409-18
10226000
EMBO J. 2004 Nov 10;23(22):4462-72
15510223
Genes Dev. 2005 Jun 15;19(12):1444-54
15933069
Exp Cell Res. 2005 Nov 1;310(2):344-56
16182285
Curr Opin Cell Biol. 2005 Dec;17(6):664-71
16226449
J Biol Chem. 2005 Nov 18;280(46):38814-22
16166085
Science. 2005 Dec 2;310(5753):1487-9
16322456
Dev Cell. 2005 Dec;9(6):855-61
16326396
Nat Med. 2005 Dec;11(12):1351-4
16288281
Nat Cell Biol. 2006 Jul;8(7):764-70
16767079
Semin Cancer Biol. 2006 Aug;16(4):253-64
16904903
Semin Cancer Biol. 2006 Aug;16(4):242-52
16935524
Curr Opin Genet Dev. 2006 Oct;16(5):502-7
16844365
J Invest Dermatol. 2007 May;127(5):1126-39
17195011